Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05588947
Other study ID # Version 1.0 25Sept2022
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date October 10, 2022
Est. completion date November 10, 2023

Study information

Verified date October 2022
Source University of Calgary
Contact Vivian WY Fu, PhD
Phone 5879687352
Email vivian.fu@ucalgary.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Take Charge is a novel, community-based treatment for stroke developed to harness a person's self-determination. Two prior clinical trials with 572 stroke survivors showed that Take Charge improves quality of life, independence, and social participation up to a year after stroke. Take Charge has also been shown to be overall cost-saving to the health system and is a useful adjunct to standard care after stroke. Because of the COVID-19 pandemic, a lot of healthcare has moved into a telehealth approach. The simplicity of Take Charge may lend itself to being effective if delivered by telehealth, allowing greater access for people with stroke in rural communities. Improving the care we provide in underserved regions of the country is important to help the health of Canadians. We are proposing a new study, working closely with the researchers who ran the previous Take Charge studies. The goal of this feasibility clinical trial is to learn about Tele-Take Charge in adults with stroke who live in Southern Alberta. The main questions it aims to answer are: - is delivering Take Charge by telehealth feasible? - is Take Charge by telehealth acceptable to this population? Participants will meet with facilitators online via Zoom at 4 to 16 weeks after stroke, and be randomized to receive either: - two Tele-Take Charge sessions six weeks apart - one control tele-education session. Researchers will compare the Tele-Take Charge and control groups to see if there are any differences in outcome measures. these differences will help researchers to estimate the number of participants that will be needed for a larger, multi-centred effectiveness trial.


Description:

For adults diagnosed with acute stroke who are discharged to community living (non-institutionalized), we wish to evaluate whether delivering two Take Charge sessions by telehealth is (1) acceptable to the population of Southern Alberta, and (2) feasible to do. Subjects will be randomly assigned to receive either two Tele-Take Charge sessions or one tele-education session (Life After Stroke video) by telehealth (the active control). The primary feasibility outcome will be recruitment rate. Secondary outcomes will be measured by a blinded outcomes assessor at 6 and 12 months, either by e-questionnaire or by telephone. Those who received Tele-Take Charge will also be asked to complete an acceptability questionnaire, and will be invited to take part in an in-depth interview about their experience as part of a qualitative substudy.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 150
Est. completion date November 10, 2023
Est. primary completion date November 10, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Discharged with diagnosis of stroke to non-institutionalised community living situation - Answering 'No' to the question 'Are you fully recovered from your stroke?' (i.e., modified Rankin score [mRS] must be > 0) - Able to access video calling with a smartphone, computer, or other device Exclusion Criteria: - Major comorbid illness that would dictate functional outcome at 12 months or life expectancy < 12 months - Pre-stroke dependency (mRS > 2 before index stroke)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Take Charge session
A 'talk therapy' session designed to harness the person's self-determination, re-establishing purpose, identity, autonomy, and skills to Take Charge of their recovery after stroke
Active Control
Life After Stroke educational video

Locations

Country Name City State
Canada Dr Vernon Fanning CareWest Rehabilitation Centre Calgary
Canada Foothills Medical Centre Calgary

Sponsors (1)

Lead Sponsor Collaborator
University of Calgary

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of recruitment Number of participants recruited per month 12 months
Secondary Eligibility Number of people meeting eligibility criteria 12 months
Secondary Treatment adherence Number receiving both sessions 12 months
Secondary Acceptability of Tele-TaCAS Participant acceptability questionnaire 2 weeks after receiving Tele-TaCAS
Secondary Health-related quality of life Physical Component Summary score of the Short Form 36
The PCS of the SF-36 is a psychometrically robust measure of health-related quality of life. The score is formed from an algorithm comprising 36 questions that assess functional health and well-being from the perspective of the patient. The items contribute to eight health domains of physical functioning, role limitations due to physical problems, bodily pain, general health, vitality, social functioning, role limitations due to emotional problems and mental health. The eight domains all contribute to physical component summary (PCS) and mental component summary (MCS) scores. The minimal clinically important difference (MCID) of the PCS in stroke is estimated to be 2.5.
6 and 12 months after stroke
Secondary Independence - modified Rankin scale 0 to 2 The modified Rankin scale (mRS) is a global disability measure used commonly in acute stroke trials. The scale ranges from 0 to 6. 0 = no symptoms, 1 = able to carry out all usual activities despite symptoms, 2 = able to look after own affairs without assistance but unable to carry out all usual activities, 3 moderate disability, unable to look after own affairs but able to walk without assistance, 4 = unable to attend to own bodily needs or unable to walk without assistance, 5 = severe disability, bedridden, 6 = dead. 6 and 12 months after stroke
Secondary Activities of Daily Living - Barthel Index The Barthel Index (BI) measures a person's current ability to do 10 different common activities with or without assistance, including bathing, walking upstairs, toileting, and feeding. The total scores range from 0 to 20, with a higher score representing more independence. 6 and 12 months after stroke
Secondary Instrumental Activities of Daily Living / Social Participation - Frenchay Activities Index The Frenchay Activities Index (FAI) is a measure of instrumental activities of daily living that assesses a broad range of activities associated with everyday life that a patient has participated in within the recent past. These can be separated into three domains: domestic chores, leisure/work, and outdoor activities. The patient self-reports how frequently each activity was done in the prior 3-6 months, and the total score can range from 0 to 45. The higher the score, the more social participation has been reported. 6 and 12 months after stroke
Secondary Quality of Life - EQ5D5L European Quality of Life 5 Dimension 5 Levels (EQ-5D-5L) is a self-reported measure of global quality of life in five domains and at five levels. There is also a visual analogue scale from 0 - 100 to self-rate how healthy a person feels that particular day. 6 and 12 months after stroke
Secondary Self-Determination - AMP-C An Autonomy Mastery Purpose Connectedness score derived by our group with four statements and self-reported level of agreement on a Likert scale. Not validated but measured in the last Take Charge trial. 6 and 12 months after stroke
See also
  Status Clinical Trial Phase
Recruiting NCT05570682 - Manually Controlled Infusion vs Target Controlled Infusion for StrokeThrombectomy N/A
Recruiting NCT04504214 - Tendon Vibrations Effect on Upper Limb Motor Recovery After Recent Stroke N/A
Recruiting NCT06179745 - BCI Driving FES and Hand Orthosis for Upper Limb Rehabilitation in Chronic Stroke N/A
Recruiting NCT04188522 - Imaging Post-Stroke Recovery: Using MEG to Evaluate Cognition
Recruiting NCT06291480 - Music Therapy After Stroke (Subacute Phase) N/A
Active, not recruiting NCT06365931 - Physiological and Functional Effects of Percutaneous Neuromodulation vs Transcutaneous Neuromodulation N/A
Recruiting NCT05878457 - Accelerated rTMS for Post-Stroke Apathy Phase 1
Recruiting NCT05657392 - Quantitative EEG Changes Following Repetitive Transcranial Magnetic Stimulation in Patients With Post Stroke (EEG-rTMS) N/A
Temporarily not available NCT05522569 - Expanded Access Multi-Patient Experimental Treatment Involving Allogeneic Human Mesenchymal Stem Cells (hMSCs) in Subjects With Acute Ischemic Stroke (EXPAND)